Total Payments
$15,822
2024 Payments
$2,129
Companies
55
Transactions
1,287
Medicare Patients
4,588
Medicare Billing
$398,661
Payment Breakdown by Category
Food & Beverage$15,680 (99.1%)
Education$142.80 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,680 | 1,280 | 99.1% |
| Education | $142.80 | 7 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,260 | 186 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,589 | 48 | $0 (2024) |
| Lilly USA, LLC | $1,384 | 132 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,136 | 104 | $0 (2024) |
| PFIZER INC. | $1,116 | 96 | $0 (2024) |
| Amgen Inc. | $877.90 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $773.31 | 93 | $0 (2024) |
| ABBVIE INC. | $745.59 | 62 | $0 (2024) |
| Astellas Pharma US Inc | $602.94 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $592.29 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,129 | 120 | Novo Nordisk Inc ($404.10) |
| 2023 | $2,188 | 141 | Novo Nordisk Inc ($331.58) |
| 2022 | $1,366 | 96 | Lilly USA, LLC ($194.92) |
| 2021 | $83.04 | 1 | AstraZeneca Pharmaceuticals LP ($83.04) |
| 2020 | $603.38 | 42 | Amgen Inc. ($116.54) |
| 2019 | $3,059 | 274 | Novo Nordisk Inc ($354.21) |
| 2018 | $3,061 | 292 | Novo Nordisk Inc ($573.09) |
| 2017 | $3,333 | 321 | Novo Nordisk Inc ($410.05) |
All Payment Transactions
1,287 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: UROLOGY | ||||||
| 11/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Obesity | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,105 | 1,311 | $185,526 | $83,783 |
| 2022 | 18 | 1,249 | 3,158 | $268,250 | $117,339 |
| 2021 | 17 | 1,050 | 3,068 | $237,126 | $104,173 |
| 2020 | 22 | 1,184 | 2,969 | $238,950 | $93,366 |
Total Patients
4,588
Total Services
10,506
Medicare Billing
$398,661
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 213 | 213 | $58,788 | $25,583 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 265 | 444 | $55,092 | $22,084 | 40.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 92 | 92 | $9,200 | $6,975 | 75.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 89 | $15,627 | $6,261 | 40.1% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 38 | 38 | $7,448 | $5,434 | 73.0% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 15 | 15 | $7,020 | $3,619 | 51.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 109 | 109 | $3,799 | $3,121 | 82.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $6,936 | $2,612 | 37.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 52 | $3,744 | $1,706 | 45.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 38 | 38 | $2,280 | $1,450 | 63.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 38 | 38 | $2,280 | $1,450 | 63.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 22 | 27 | $9,423 | $1,392 | 14.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $1,176 | $822.48 | 69.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $816.00 | $687.12 | 84.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 49 | $1,519 | $466.48 | 30.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 49 | 54 | $378.00 | $118.80 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 313 | 600 | $68,370 | $31,769 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 234 | 234 | $64,584 | $28,650 | 44.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 1,560 | $65,520 | $25,153 | 38.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 108 | 114 | $11,172 | $7,702 | 68.9% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2022 | 15 | 15 | $7,020 | $3,632 | 51.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 112 | 119 | $4,160 | $3,254 | 78.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 40 | $6,520 | $2,999 | 46.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 16 | 16 | $6,320 | $2,526 | 40.0% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 64 | 64 | $3,840 | $2,314 | 60.3% |
About Dr. Todd Rhoades, MD
Dr. Todd Rhoades, MD is a Family Medicine healthcare provider based in Anderson, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487676706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Rhoades, MD has received a total of $15,822 in payments from pharmaceutical and medical device companies, with $2,129 received in 2024. These payments were reported across 1,287 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($15,680).
As a Medicare-enrolled provider, Rhoades has provided services to 4,588 Medicare beneficiaries, totaling 10,506 services with total Medicare billing of $398,661. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Anderson, IN
- Active Since 07/24/2006
- Last Updated 11/27/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487676706
Products in Payments
- FARXIGA (Drug) $855.78
- JARDIANCE (Drug) $765.39
- VRAYLAR (Drug) $646.22
- Kerendia (Drug) $592.29
- Ozempic (Drug) $564.14
- CHANTIX (Drug) $432.95
- XARELTO (Drug) $420.67
- MOUNJARO (Drug) $382.10
- Rybelsus (Drug) $332.56
- TRULICITY (Drug) $328.96
- Dexcom G6 Transmitter (Medical Supply) $308.64
- JANUVIA (Drug) $302.70
- Victoza (Drug) $275.29
- Tresiba (Drug) $263.10
- BREZTRI (Drug) $262.66
- Aimovig (Biological) $255.72
- MYRBETRIQ (Drug) $253.44
- NURTEC ODT (Drug) $250.96
- ANORO (Drug) $249.58
- UBRELVY (Drug) $248.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Anderson
Samuel Shaver, Md, MD
Family Medicine — Payments: $26,779
Family Medicine $26,779
Charles Williams, Md, MD
Family Medicine — Payments: $17,772
Family Medicine $17,772
Dr. Nirmal Mehton, Md, MD
Family Medicine — Payments: $15,586
Family Medicine $15,586
Joseph Abraham, M.d, M.D
Family Medicine — Payments: $15,298
Family Medicine $15,298
Erin Cooksey Harrington, Md, MD
Family Medicine — Payments: $11,651
Family Medicine $11,651
Christine Lawrence, Md, MD
Family Medicine — Payments: $11,098
Family Medicine $11,098